• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒的Gag p24蛋白改变免疫蛋白酶体的组成并影响抗原呈递。

Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.

作者信息

Steers Nicholas J, Peachman Kristina K, McClain Sasha R, Alving Carl R, Rao Mangala

机构信息

Henry M Jackson Foundation, Division of Retrovirology, USMHRP, Walter Reed Army Institute of Research, Rockville, MD 20850, USA.

出版信息

J Virol. 2009 Jul;83(14):7049-61. doi: 10.1128/JVI.00327-09. Epub 2009 Apr 29.

DOI:10.1128/JVI.00327-09
PMID:19403671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2704757/
Abstract

Proteasomes are the major source of proteases responsible for the generation of peptides bound to major histocompatibility complex class I molecules. Antigens, adjuvants, and cytokines can modulate the composition and enzymatic activity of proteasomes and thus alter the epitopes generated. In the present study, we examined the effect of human immunodeficiency virus type 1 (HIV-1) p24 on proteasomes from a dendritic cell line (JAWS II), from a macrophage cell line (C2.3), and from murine primary bone marrow-derived macrophages and dendritic cells. HIV-1 p24 downregulated PA28beta and the beta2i subunit of the immunoproteasome complex in JAWS II cells but did not decrease the immunoproteasome subunits in macrophages, whereas in primary dendritic cells, PA28alpha, beta2i, and beta5i were downregulated. Exposure of JAWS II cells and primary dendritic cells to HIV-1 p24 for 90 min significantly decreased the presentation of ovalbumin to a SIINFEKL-specific CD8(+) T-cell hybridoma. The decrease in antigen presentation and the downmodulation of the immunoproteasome subunits in JAWS II cells and primary dendritic cells could be overcome by pretreating the cells with gamma interferon for 6 h or by exposing the cells to HIV-1 p24 encapsulated in liposomes containing lipid A. These results suggest that early antigen processing kinetics could influence the immunogenicity of CD8(+) T-cell epitopes generated.

摘要

蛋白酶体是负责生成与主要组织相容性复合体I类分子结合的肽段的蛋白酶的主要来源。抗原、佐剂和细胞因子可调节蛋白酶体的组成和酶活性,从而改变所产生的表位。在本研究中,我们检测了1型人类免疫缺陷病毒(HIV-1)p24对来自树突状细胞系(JAWS II)、巨噬细胞系(C2.3)以及小鼠原代骨髓来源的巨噬细胞和树突状细胞的蛋白酶体的影响。HIV-1 p24下调了JAWS II细胞中PA28β和免疫蛋白酶体复合物的β2i亚基,但未降低巨噬细胞中的免疫蛋白酶体亚基,而在原代树突状细胞中,PA28α、β2i和β5i均被下调。将JAWS II细胞和原代树突状细胞暴露于HIV-1 p24 90分钟,显著降低了卵清蛋白向SIINFEKL特异性CD8(+) T细胞杂交瘤的呈递。通过用γ干扰素预处理细胞6小时或使细胞暴露于包封在含有脂多糖的脂质体中的HIV-1 p24,可克服JAWS II细胞和原代树突状细胞中抗原呈递的减少和免疫蛋白酶体亚基的下调。这些结果表明,早期抗原加工动力学可能影响所产生的CD8(+) T细胞表位的免疫原性。

相似文献

1
Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.1型人类免疫缺陷病毒的Gag p24蛋白改变免疫蛋白酶体的组成并影响抗原呈递。
J Virol. 2009 Jul;83(14):7049-61. doi: 10.1128/JVI.00327-09. Epub 2009 Apr 29.
2
Modulation of immunoproteasome subunits by liposomal lipid A.脂质体脂多糖对免疫蛋白酶体亚基的调节作用。
Vaccine. 2008 Jun 2;26(23):2849-59. doi: 10.1016/j.vaccine.2008.03.065. Epub 2008 Apr 14.
3
Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein.从 HIV gag p24 蛋白中鉴定树突状细胞加工的 CD4+ T 细胞表位的策略。
PLoS One. 2012;7(7):e41897. doi: 10.1371/journal.pone.0041897. Epub 2012 Jul 30.
4
Dendritic cells, infected with vesicular stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals.感染水泡性口炎病毒假型化HIV-1的树突状细胞,将病毒抗原呈递给来自HIV-1感染者的CD4+和CD8+ T细胞。
J Immunol. 2000 Dec 1;165(11):6620-6. doi: 10.4049/jimmunol.165.11.6620.
5
Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.HIV-1 Gag-p24 的细胞类型特异性蛋白酶体加工导致表位谱发生改变。
J Virol. 2011 Feb;85(4):1541-53. doi: 10.1128/JVI.01790-10. Epub 2010 Nov 24.
6
Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses.用聚乳酸 - p24纳米颗粒或表达HIV基因的痘苗病毒感染树突状细胞可诱导HIV - 1特异性T细胞反应。
Vaccine. 2014 Oct 29;32(47):6266-76. doi: 10.1016/j.vaccine.2014.09.010. Epub 2014 Sep 19.
7
Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.热休克蛋白介导的外源性HIV抗原在HLA I类和II类分子上的交叉呈递。
J Immunol. 2004 Aug 1;173(3):1987-93. doi: 10.4049/jimmunol.173.3.1987.
8
Mice completely lacking immunoproteasomes show major changes in antigen presentation.缺乏免疫蛋白酶体的小鼠在抗原呈递方面表现出重大变化。
Nat Immunol. 2011 Dec 25;13(2):129-35. doi: 10.1038/ni.2203.
9
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.抗原加工影响HIV特异性细胞毒性T淋巴细胞免疫显性。
Nat Immunol. 2009 Jun;10(6):636-46. doi: 10.1038/ni.1728. Epub 2009 May 3.
10
Immunoproteasome Subunits Are Required for CD8 T Cell Function and Host Resistance to Brucella abortus Infection in Mice.免疫蛋白酶体亚基是 CD8 T 细胞功能所必需的,也是宿主抵抗布鲁氏菌流产感染所必需的。
Infect Immun. 2018 Feb 20;86(3). doi: 10.1128/IAI.00615-17. Print 2018 Mar.

引用本文的文献

1
Susceptibility to Lenacapavir Among Newly Diagnosed HIV-Positive Patients Followed Up in Mozambique That Presented With Primary Antiretroviral Resistance to Other Classes.在莫桑比克接受随访的新诊断出的HIV阳性患者中,对其他类别药物存在原发性抗逆转录病毒耐药性的患者对来那卡韦的敏感性。
J Med Virol. 2025 Mar;97(3):e70317. doi: 10.1002/jmv.70317.
2
In silico designing of novel epitope-based peptide vaccines against HIV-1.针对 HIV-1 的新型基于表位的肽疫苗的计算机设计。
Biotechnol Lett. 2024 Jun;46(3):315-354. doi: 10.1007/s10529-023-03464-x. Epub 2024 Feb 26.
3
YWHAH, a member of 14-3-3 family proteins, and PSME2, the proteasome activator subunit 2, are key host factors of Japanese encephalitis virus infection.YWHAH,一种 14-3-3 家族蛋白成员,以及 PSME2,蛋白酶体激活亚基 2,是日本脑炎病毒感染的关键宿主因子。
BMC Med Genomics. 2023 Jul 10;16(1):161. doi: 10.1186/s12920-023-01589-6.
4
Intranasal Boosting with Spike Fc-RBD of Wild-Type SARS-CoV-2 Induces Neutralizing Antibodies against Omicron Subvariants and Reduces Viral Load in the Nasal Turbinate of Mice.鼻腔内用野生型 SARS-CoV-2 的 Spike Fc-RBD 进行增强免疫可诱导针对奥密克戎亚变种的中和抗体,并降低小鼠鼻甲骨中的病毒载量。
Viruses. 2023 Mar 6;15(3):687. doi: 10.3390/v15030687.
5
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.在接受抑制性抗逆转录病毒治疗的 HIV-1 感染者中,个体化树突状细胞治疗的免疫原性:一项 II 期临床试验的中期分析。
AIDS Res Ther. 2022 Jan 12;19(1):2. doi: 10.1186/s12981-021-00426-z.
6
Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses.免疫蛋白酶体活性和含量决定了造血细胞对 ONX-0914 和慢病毒感染细胞的敏感性。
Cells. 2021 May 12;10(5):1185. doi: 10.3390/cells10051185.
7
In Silico Design and Immunologic Evaluation of HIV-1 p24-Nef Fusion Protein to Approach a Therapeutic Vaccine Candidate.用于开发治疗性候选疫苗的HIV-1 p24-Nef融合蛋白的计算机辅助设计与免疫学评估
Curr HIV Res. 2018;16(5):322-337. doi: 10.2174/1570162X17666190102151717.
8
Heat-labile Enterotoxin B Subunit as a Platform for the Delivery of HIV Gag p24 Antigen.热不稳定肠毒素B亚基作为HIV Gag p24抗原递送平台
J Clin Cell Immunol. 2013 Apr;4(2). doi: 10.4172/2155-9899.1000140. Epub 2013 Apr 23.
9
The immunoproteasome and viral infection: a complex regulator of inflammation.免疫蛋白酶体与病毒感染:炎症的复杂调节因子。
Front Microbiol. 2015 Jan 29;6:21. doi: 10.3389/fmicb.2015.00021. eCollection 2015.
10
Computational and experimental validation of B and T-cell epitopes of the in vivo immune response to a novel malarial antigen.新型疟疾抗原体内免疫反应的 B 和 T 细胞表位的计算和实验验证。
PLoS One. 2013 Aug 16;8(8):e71610. doi: 10.1371/journal.pone.0071610. eCollection 2013.

本文引用的文献

1
Modulation of immunoproteasome subunits by liposomal lipid A.脂质体脂多糖对免疫蛋白酶体亚基的调节作用。
Vaccine. 2008 Jun 2;26(23):2849-59. doi: 10.1016/j.vaccine.2008.03.065. Epub 2008 Apr 14.
2
Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes.加工速率决定了免疫蛋白酶体产生的表位的免疫原性。
J Immunol. 2007 Jun 15;178(12):7557-62. doi: 10.4049/jimmunol.178.12.7557.
3
Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses.隐藏表位在流感病毒特异性CD8 + T细胞二次应答中出现。
J Immunol. 2007 Mar 1;178(5):3091-8. doi: 10.4049/jimmunol.178.5.3091.
4
The N-terminal flanking region of the TRP2360-368 melanoma antigen determines proteasome activator PA28 requirement for epitope liberation.TRP2360 - 368黑色素瘤抗原的N端侧翼区域决定了蛋白酶体激活剂PA28对表位释放的需求。
J Biol Chem. 2007 Apr 27;282(17):12749-54. doi: 10.1074/jbc.M611644200. Epub 2007 Feb 16.
5
Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.宿主-病原体相互作用中的抗原呈递与泛素-蛋白酶体系统
Adv Immunol. 2006;92:225-305. doi: 10.1016/S0065-2776(06)92006-9.
6
The cell biology of HIV-1 and other retroviruses.人类免疫缺陷病毒1型及其他逆转录病毒的细胞生物学
Retrovirology. 2006 Nov 3;3:77. doi: 10.1186/1742-4690-3-77.
7
Dendritic-cell interactions with HIV: infection and viral dissemination.树突状细胞与HIV的相互作用:感染与病毒传播
Nat Rev Immunol. 2006 Nov;6(11):859-68. doi: 10.1038/nri1960.
8
Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses.应对复杂性:抗病毒CD8 + T细胞反应中的真实免疫显性
Immunity. 2006 Oct;25(4):533-43. doi: 10.1016/j.immuni.2006.09.005.
9
Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.人类免疫缺陷病毒(HIV)抗原在噬菌体T4上的组装:构建多组分HIV疫苗的一种新型体外方法。
J Virol. 2006 Aug;80(15):7688-98. doi: 10.1128/JVI.00235-06.
10
Protective immunity towards intracellular pathogens.对细胞内病原体的保护性免疫。
Curr Opin Immunol. 2006 Aug;18(4):458-64. doi: 10.1016/j.coi.2006.05.008. Epub 2006 Jun 12.